Advertisements

BioPharmX Corporation. Common (BPMX) Stock Quote

Detailed Quote for BioPharmX Corporation. Common (BPMX)
$ 0.1279   0.0079 (+6.58%) Volume: 5.86m 8:00 PM EST Jan 16, 2018
After Hours:  $ 0.13   0.0021 (+1.64%) Volume: 88.76k 7:58 PM EST Jan 16, 2018
Today 5d 1m 3m 1y more
Last Price
0.1279
Change $
0.0079
Change %
6.58%
Tick
  
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
0.126
High
0.128
Low
0.118
Prev Close
0.12
Last Trade
01/16/18
Volume
5.86m
52 Wk Hi
0.897000014
52 Wk Low
0.100000001
Market Cap
16.31m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
127,508,938
EPS (TTM)
-0.230000004
PE Ratio
N/A
Exchange
NYSE American
News and Media for BioPharmX Corporation. Common (BPMX)
Sector News | Topic News
News for BioPharmX Corporation. Common (BPMX)
Fri, Jan 12, 2018
9:15 AM BioPharmX To Present BPX-04 Rosacea Data At Two Leading Clinical Conferences This Month - PR Newswire
Tue, Jan 09, 2018
7:40 AM Free Post Earnings Research Report: BioPharmX's Adjusted EPS Beat Expectations - ACCESSWIRE IA
Fri, Dec 15, 2017
7:10 AM Blog Exposure - MabVax Therapeutics Completes Enrollment and Dosing In Initial Cohort of Phase-1 Trial of Its Cancer Drug MVT-1075 - ACCESSWIRE IA
Thu, Dec 07, 2017
4:20 PM BioPharmX Corporation EPS in-line - SeekingAlpha
4:15 PM BioPharmX Reports Third Quarter 2018 Financial Results - PR Newswire
Mon, Dec 04, 2017
9:15 AM BioPharmX Demonstrates Topical Minocycline Gel May Exhibit Relevant Antimicrobial and Anti-inflammatory Properties for the Treatment of Acne at ASCB 2017 - PR Newswire
Tue, Nov 28, 2017
7:43 AM Your Daily Pharma Scoop: Synergy In 2018, Repatha Action Date, Alkermes Signs Deal - SeekingAlpha
Tue, Nov 21, 2017
9:27 AM BioPharmX prices equity offering; shares down 35% premarket - SeekingAlpha
9:05 AM BioPharmX Corporation Announces Pricing of Public Offering - PR Newswire
Thu, Nov 16, 2017
8:20 AM Report: Developing Opportunities within Graphic Packaging Holding, Invitation Home, Teradyne, Dean Foods, Valley National, and BioPharmX - Future Expectations, Projections Moving into 2018 - GlobeNewswire
Tue, Nov 14, 2017
12:14 PM Your Daily Pharma Scoop: Heron Undervalued, Theravance Submits NDA, Nektar Continues To Surge - SeekingAlpha
Thu, Nov 09, 2017
10:35 AM Planned equity offering roundup - healthcare - SeekingAlpha
Wed, Nov 08, 2017
9:15 AM BioPharmX Receives Concurrence from FDA on Phase 3 Acne Study Plans - PR Newswire
Wed, Oct 18, 2017
10:30 AM BioPharmX to Present at Re-entering Antibacterial Discovery and Development Summit 2017 - PR Newswire
Wed, Oct 11, 2017
10:30 AM BioPharmX Collaborates with Wellman Center for Photomedicine to Develop Pioneering, Cost-Effective Technique to Visualize Drug Delivery - PR Newswire
Mon, Sep 25, 2017
7:00 AM Earnings Review and Free Research Report: Can-Fite's Revenue Increased 25% - ACCESSWIRE IA
Wed, Sep 13, 2017
4:08 PM Maxim Group softens view on BioPharmX, cuts price target in half to $1.50 - SeekingAlpha
3:20 PM BioPharmX (BPMX) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow - SeekingAlpha
9:07 AM BioPharmX Corporation beats by $0.01, beats on revenue - SeekingAlpha
9:00 AM BioPharmX Reports Second Quarter 2018 Financial Results - PR Newswire
More News for BPMX >>

Tags for BioPharmX Corporation. Common

Research stocks or mutual funds related to BioPharmX Corporation. Common by keywords or tags. Find companies that have a similar focus to BPMX. The keywords below have been associated to BPMX by either user submission or electronic means.